PGEN - Precigen, Inc.
NEXT EARNINGS:
Mar 18, 2026
(in 21 days)
EPS Est: $-0.10
|
Rev Est: $8.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.00
DETAILS
HIGH:
$6.00
LOW:
$6.00
MEDIAN:
$6.00
CONSENSUS:
$6.00
UPSIDE:
50.75%
Market Cap:
1.20B
Volume:
5,727,278
Avg Volume:
4,172,203
52 Week Range:
1.11-5.47
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.07
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
143
IPO Date:
2013-08-08
EPS (TTM):
-0.47
P/E Ratio:
-2.38
Revenue (TTM):
3.92M
Total Assets:
145.27M
Total Debt:
5.50M
Cash & Equiv:
29.52M
Rev Growth (5Y):
-34.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-103.5%
Debt/Equity:
0.14
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $-0.11 | $-0.08 | -37.5% | $2.9M | $8.3M | -64.7% |
| 2025-08-12 | $-0.11 | $-0.14 | +21.4% | $856000 | $933330 | -8.3% |
| 2025-05-14 | $-0.07 | $-0.08 | +12.5% | $1.3M | $500000 | +168.2% |
| 2025-03-19 | $-0.04 | $-0.06 | +33.3% | $1.2M | $733330 | +62.3% |
| 2024-11-14 | $-0.09 | $-0.08 | -12.5% | $953000 | $1.3M | -26.7% |
| 2024-08-14 | $-0.10 | $-0.09 | -11.1% | $717000 | $1.3M | -44.0% |
| 2024-05-14 | $-0.10 | $-0.09 | -11.1% | $1.1M | $1.5M | -28.0% |
| 2024-02-13 | $-0.13 | $-0.08 | -62.5% | $1.2M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.92M | 6.22M | 26.91M | 14.27M | 31.99M | 31.99M | 160.57M | 230.98M | 190.93M | 173.60M | 71.93M | 23.76M |
| Net Income | (126.23M) | (95.90M) | 28.32M | (92.17M) | (170.52M) | (170.52M) | (509.34M) | (117.02M) | (186.61M) | (84.49M) | (81.82M) | (38.98M) |
| EPS | -0.47 | -0.39 | -0.33 | -0.47 | -1.02 | -1.35 | -3.93 | -0.98 | -1.58 | -0.76 | -0.83 | -0.95 |
| Total Assets | 145.27M | 151.04M | 215.98M | 359.86M | 314.59M | 455.76M | 716.18M | 846.85M | 949.07M | 982.05M | 576.27M | 469.47M |
| Total Debt | 5.50M | 7.10M | 51.42M | 190.07M | 182.28M | 232.67M | 212.26M | 8.27M | 8.77M | 9.09M | 12.64M | 1.69M |
| Cash & Equivalents | 29.52M | 7.58M | 4.86M | 36.42M | 51.79M | 65.79M | 102.77M | 68.11M | 62.61M | 135.78M | 27.47M | 49.51M |
| Operating Cash Flow | (68.17M) | (66.93M) | (65.05M) | (55.77M) | (77.02M) | (77.02M) | (124.24M) | (104.14M) | (55.98M) | 35.67M | (19.86M) | (53.68M) |
| Free Cash Flow | (76.76M) | (68.47M) | (69.97M) | (63.02M) | (84.55M) | (84.55M) | (165.83M) | (150.81M) | (87.60M) | 22.92M | (26.23M) | (55.21M) |
| FCF per Share | -0.29 | -0.28 | -0.35 | -0.32 | -0.51 | -0.55 | -1.28 | -1.26 | -0.74 | 0.21 | -0.26 | -1.35 |
| Book Value | 38.51M | 118.50M | 126.26M | 107.35M | 67.17M | 71.71M | 362.86M | 533.63M | 560.24M | 694.08M | 384.76M | 366.72M |
| Cash & ST Investments | 97.91M | 62.85M | 55.95M | 108.66M | 100.12M | 75.05M | 222.84M | 79.67M | 237.21M | 238.31M | 115.96M | 177.49M |
| ROC Equity | -3.28 | -0.81 | 0.22 | -0.86 | -2.54 | -2.38 | -1.40 | -0.22 | -0.33 | -0.12 | -0.21 | -0.11 |